Posted July 16, 2020 by Olive View Internal Medicine Residency
Last updated November 3, 2020 by Olive View Internal Medicine Residency
Landmark Research Series
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis (RAVE)
Dates: July 1, 2020 - July 31, 2020
Comparison of carvedilol and metoprolol on clinical outcomes in patients with CHF (COMET)
Clinical Question: What is the effect of carvedilol vs metoprolol tartrate on mortality and morbidity in patients with heart failure with reduced ejection fraction (HFrEF) and NYHA class II-IV symptoms?
Take Away: In patients with HFrEF, carvedilol reduces all-cause mortality compared to metoprolol tartrate.
Intensive versus Conventional Glucose Control in Critically Ill Patients (NICE-SUGAR)
Dates: October 1, 2020 - October 31, 2020
This classic, often-cited article informs us that among patients in the ICU, intensive glucose control of 81-108 increased mortality as compared to a more liberal glucose target of <180. How have you applied the findings of this research to your practice?
Rosuvastatin to Prevent Vascular Events (JUPITER)
Dates: November 1, 2020 - November 30, 2020